L-glutamine
Also called: glutamine
L-glutamine is the most abundant amino acid in muscle, blood and the body's free-amino-acid pool. The body makes it mainly from branched-chain amino acids, and adults get about 3–6 g/day from protein foods. Supplements come as pills or powder.
- Category
- Amino acid and protein
- Forms
- L-glutamine (oral; pill or powder)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2020 meta-analysis (Frontiers in Nutrition) included 6 RCTs (441 adults with head and neck cancer) of oral glutamine versus placebo or no treatment during radiotherapy; 5 RCTs (279 patients) were pooled for oral mucositis. [5]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BSeveral areas, whole body or blood2 topics
CMuscles and exercise1 topic
XCancer1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Athletic performance, body composition and immune measures in athletes | C | A 2019 meta-analysis (25 trials) found glutamine generally had no effect on immune measures, aerobic performance or body composition in athletes, but reported greater weight reduction (weighted mean difference −1.36). [4] |
| Strength and muscle recovery | C | ODS: few studies tested glutamine alone; in a 6-week trial (31 weightlifters, about 45 g/day) groups did not differ in strength or lean mass, and ODS concludes research does not support glutamine alone for performance. [1] |
| Radiation-induced oral mucositis in head and neck cancer | X | A 2020 meta-analysis of 6 RCTs (441 patients) found oral glutamine did not significantly lower the incidence or severity of oral mucositis during radiotherapy; it may have slightly reduced opioid use. [5] |
| Pain crises in sickle cell disease (pharmaceutical-grade L-glutamine) | B | In a 48-week phase 3 RCT (230 patients aged 5–58), oral L-glutamine 0.3 g/kg twice daily was followed by fewer pain crises (median 3.0 vs 4.0) and fewer hospitalizations than placebo. [6] |
Main constituents: L-glutamine, which the body makes to build protein [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Weightlifter trial described by ODS: about 45 g/day (0.9 g/kg lean body mass) for 6 weeks; muscle-recovery trial: four doses of 0.3 g/kg over 3 days. [1]
- Sickle cell phase 3 trial: pharmaceutical-grade L-glutamine 0.3 g per kilogram of body weight per dose, twice daily by mouth, for 48 weeks. [6]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)See details
Single case report only: MSK cites one case of suspected liver injury in a 35-year-old female athlete after three weeks of glutamine powder …
Details and sources - Pregnancy and breastfeedingHealth Canada's L-glutamine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Lactulose; Methotrexate
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada NNHPD L-glutamine monograph (January 30, 2026), adults 18 years and older: 5–9 grams of L-glutamine per day.
Details and sources
- ODS: no side effects were reported in the exercise studies; in patients with serious catabolic illnesses, daily oral doses of 0.21 to 0.42 g/kg body weight (15–30 g/day for a 154-pound person) showed no biochemical or clinical evidence of toxicity. [1]
- MSK lists reported peripheral edema, gastrointestinal symptoms, headache, fever and infections, and cites a single case report of suspected liver injury in a 35-year-old female athlete after three weeks of glutamine powder (she recovered after stopping) and a case of acute kidney injury after long-term use of 18 grams of L-glutamine. [2]
- In the sickle cell trial, low-grade nausea, noncardiac chest pain, fatigue and musculoskeletal pain occurred more often with L-glutamine than placebo. [6]
- FDA lists the common adverse reactions (over 10% of patients) for the drug product Endari as constipation, nausea, headache, abdominal pain, cough, pain in extremity, back pain and chest pain. [7]
- Health Canada requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [3]
Interactions
| With | What happens |
|---|---|
| Lactulose | MSK states glutamine may reduce the ammonia-lowering effect of lactulose (not relevant when lactulose is used as a laxative). [2] |
| Methotrexate | MSK states glutamine may preferentially increase tumor retention of methotrexate, thereby increasing its therapeutic efficacy. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- MSK cautions not to confuse glutamine with glutamate; excess glutamate can cause seizures and brain cell death. [2]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [8]
- US drug product: on July 7, 2017, the U.S. Food and Drug Administration approved L-glutamine oral powder (Endari) for oral administration to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years and older. This approval is for that drug product. [7]
- Canada: Health Canada's L-glutamine monograph (oral, January 30, 2026) includes the use "Helps to assist in muscle cell repair after exercise." [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming glutamine-containing compounds, creatyl-L-glutamine and L-alanyl-L-glutamine; none names L-glutamine alone (earliest NDI 676 submitted 2010-10-19; most recent NDI 1191 submitted 2020-12-15). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
- Separately, on July 7, 2017, the U.S. Food and Drug Administration approved L-glutamine oral powder (Endari), a drug product, for oral administration to reduce the acute complications of sickle cell disease in patients 5 years and older; this does not concern dietary supplements. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- Single case report only: MSK cites one case of suspected liver injury in a 35-year-old female athlete after three weeks of glutamine powder; she recovered after stopping glutamine. [P8]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P5]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada NNHPD L-glutamine monograph (January 30, 2026), adults 18 years and older: 5–9 grams of L-glutamine per day. [P6]
Pregnancy and breastfeeding
- Health Canada's L-glutamine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [P6]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- U.S. Food and Drug Administration. FDA approved L-glutamine powder for the treatment of sickle cell disease (July 7, 2017), 2017-07-07. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports index (TR-000 to TR-606, checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- Health Canada, NNHPD. Monograph: L-Glutamine (date 2026-01-30), 2026-01-30. webprod.hc-sc.gc.ca
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Glutamine (Last Updated September 25, 2026), 2026-09-25. mskcc.org
Sources
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Glutamine (Last Updated September 25, 2026), 2026-09-25. mskcc.org
- Health Canada, NNHPD. Monograph: L-Glutamine (date 2026-01-30), 2026-01-30. webprod.hc-sc.gc.ca
- Ramezani Ahmadi A, et al. The effect of glutamine supplementation on athletic performance, body composition, and immune function: a systematic review and a meta-analysis of clinical trials. Clin Nutr 2019;38(3):1076-1091 (PMID 29784526), 2019-06. pubmed.ncbi.nlm.nih.gov
- Shuai T, et al. Oral glutamine may have no clinical benefits to prevent radiation-induced oral mucositis in adult patients with head and neck cancer: a meta-analysis of randomized controlled trials. Front Nutr 2020;7:49 (PMID 32363198), 2020-04-17. pubmed.ncbi.nlm.nih.gov
- Niihara Y, et al. A phase 3 trial of l-glutamine in sickle cell disease. N Engl J Med 2018;379(3):226-235 (PMID 30021096), 2018-07-19. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. FDA approved L-glutamine powder for the treatment of sickle cell disease (July 7, 2017), 2017-07-07. fda.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.